Create Medic (5187) Q3 2025 earnings summary

Executive summary

• Net sales for the nine months ended September 30, 2025, increased by 5.7% year-over-year to ¥10,054 million.

• Operating profit rose 75.3% year-over-year to ¥913 million, and ordinary profit increased 59.9% to ¥871 million.

• Profit attributable to owners of parent declined 10.5% year-over-year to ¥666 million.

Financial highlights

• Comprehensive income for the nine months was ¥382 million, down 57.0% year-over-year.

• Basic earnings per share for the period was ¥78.45, compared to ¥83.85 in the prior year.

• Total assets as of September 30, 2025, were ¥19,151 million, down from ¥20,047 million at the end of 2024.

• Net assets stood at ¥15,623 million, with a capital adequacy ratio of 81.6%.

Outlook and guidance

• Full-year 2025 net sales are forecast at ¥13,583 million, up 4.2% year-over-year.

• Operating profit is projected to rise 44.7% to ¥1,002 million, and ordinary profit to increase 39.0% to ¥1,043 million.

• Profit attributable to owners of parent is expected to decrease 5.3% to ¥796 million, with basic EPS of ¥92.67.

• No revisions to previously announced earnings or dividend forecasts.